Last week fifteen states dropped opposition to Purdue Pharma’s bankruptcy exit plan, making it likely the plan will be approved when it comes before a federal bankruptcy judge in August.
Wednesday, October 22, 2025
Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
The largest drug companies are far more interested in enriching themselves and investors than in developing new drugs, according to a House committee report released Thursday
New York City Subway Flooding Demonstrates Transit System Vulnerability to Climate Change
More frequent and severe New York City subway floods demonstrate how climate change is crippling critical infrastructure.
Book Review: The History of Animal-Based Medicine in China
Even critics of animal-based potions in China don’t understand its origins….which means they may be easier to contain than is now assumed.
Musical Interlude (“On the Path of Decent Groove”): Bombast
Bombast is where my head is right now. And you?
2:00PM Water Cooler 7/9/2021
~ Today’s Water Cooler ~
Trump Can’t Beat Facebook, Twitter and YouTube in Court – but the Fight Might Be Worth More Than a Win
Trump is back for another misguided, erm, quixotic fight. Could he still score points?
Moving the Covid Vaccine Goalposts
The Covid propagation and vaccine news is not pointing to happy outcomes
Wall Street Journal Fingers Columbia as Leader in Grad Students Whose Student Debt Leaves Them ‘Financially Hobbled for Life’
Columbia stands out in what a bad deal its graduate arts programs are. And President Bollinger is either clueless or indifferent.
The Future of Alzheimer’s Pharmaceutical Aducanumab – as a Medicine and as a Financial Product – What Happens Now?
The more you look at aducanumab, both the dubious FDA approval and the thin odds that it will perform medically, the less there is to like.
2:00PM Water Cooler 7/8/2021
~ Today’s Water Cooler ~
War on Science Persists Within Biden EPA as Staffers Allege Chemical Reports Altered
Whistleblowers charge that Trump-style doctoring of scientific reports is continuing under Biden.
